Cannara Biotech Stock Price Prediction
| LOVE Stock | CAD 0.70 0.02 2.78% |
Oversold Vs Overbought
60
Oversold | Overbought |
Quarterly Earnings Growth (0.33) | Quarterly Revenue Growth 0.226 |
Using Cannara Biotech hype-based prediction, you can estimate the value of Cannara Biotech from the perspective of Cannara Biotech response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Cannara Biotech to buy its stock at a price that has no basis in reality. In that case, they are not buying Cannara because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Cannara Biotech after-hype prediction price | CAD 0.68 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Cannara |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cannara Biotech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Cannara Biotech After-Hype Price Prediction Density Analysis
As far as predicting the price of Cannara Biotech at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Cannara Biotech or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Cannara Biotech, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Cannara Biotech Estimiated After-Hype Price Volatility
In the context of predicting Cannara Biotech's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Cannara Biotech's historical news coverage. Cannara Biotech's after-hype downside and upside margins for the prediction period are 0.03 and 6.91, respectively. We have considered Cannara Biotech's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Cannara Biotech is out of control at this time. Analysis and calculation of next after-hype price of Cannara Biotech is based on 3 months time horizon.
Cannara Biotech Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Cannara Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cannara Biotech backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Cannara Biotech, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.29 | 6.28 | 0.02 | 0.00 | 1 Events / Month | 1 Events / Month | Very soon |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.70 | 0.68 | 2.86 |
|
Cannara Biotech Hype Timeline
Cannara Biotech is now traded for 0.70on TSX Venture Exchange of Canada. The entity has historical hype elasticity of -0.02, and average elasticity to hype of competition of 0.0. Cannara is anticipated to decline in value after the next headline, with the price expected to drop to 0.68. The average volatility of media hype impact on the company price is over 100%. The price drop on the next news is expected to be -2.86%, whereas the daily expected return is now at 0.29%. The volatility of related hype on Cannara Biotech is about 179428.57%, with the expected price after the next announcement by competition of 0.70. About 49.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.74. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Cannara Biotech had not issued any dividends in recent years. The entity had 1:10 split on the 13th of February 2023. Assuming the 90 days trading horizon the next anticipated press release will be very soon. Check out Cannara Biotech Basic Forecasting Models to cross-verify your projections.Cannara Biotech Related Hype Analysis
Having access to credible news sources related to Cannara Biotech's direct competition is more important than ever and may enhance your ability to predict Cannara Biotech's future price movements. Getting to know how Cannara Biotech's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Cannara Biotech may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| DB | Decibel Cannabis | (0) | 1 per month | 4.85 | 0.04 | 14.29 | (10.00) | 39.08 | |
| LOVE | Cannara Biotech | (0.08) | 1 per month | 4.91 | 0.04 | 12.86 | (7.69) | 33.46 | |
| XHB | iShares Canadian HYBrid | (0.06) | 3 per month | 0.15 | (0.07) | 0.51 | (0.35) | 1.52 | |
| ALA-PA | Altagas Cum Red | 0.00 | 0 per month | 0.64 | 0.05 | 1.15 | (1.45) | 3.73 | |
| ERE-UN | European Residential Real | 0.04 | 4 per month | 1.02 | 0.10 | 2.30 | (1.58) | 20.23 | |
| CLU | iShares Fundamental Hedged | 0.24 | 2 per month | 0.58 | (0.05) | 1.02 | (0.97) | 5.88 | |
| RUDB | RBC Discount Bond | 0.05 | 1 per month | 0.21 | 0.07 | 0.70 | (0.47) | 1.96 | |
| BN-PFI | Brookfield | 0.00 | 0 per month | 0.40 | 0.09 | 1.34 | (1.01) | 2.73 | |
| XEG | iShares SPTSX Capped | (0.15) | 1 per month | 0.00 | (0.03) | 2.20 | (2.24) | 8.20 | |
| SOLI-P | Solid Impact Investments | 0.00 | 1 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cannara Biotech Additional Predictive Modules
Most predictive techniques to examine Cannara price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cannara using various technical indicators. When you analyze Cannara charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Cannara Biotech Predictive Indicators
The successful prediction of Cannara Biotech stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Cannara Biotech, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Cannara Biotech based on analysis of Cannara Biotech hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Cannara Biotech's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Cannara Biotech's related companies. | 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 67.52 | 58.21 | 55.3 | PTB Ratio | 1.12 | 0.7 | 0.66 |
Story Coverage note for Cannara Biotech
The number of cover stories for Cannara Biotech depends on current market conditions and Cannara Biotech's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Cannara Biotech is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Cannara Biotech's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Cannara Biotech Short Properties
Cannara Biotech's future price predictability will typically decrease when Cannara Biotech's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Cannara Biotech often depends not only on the future outlook of the potential Cannara Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cannara Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 90.3 M |
Additional Tools for Cannara Stock Analysis
When running Cannara Biotech's price analysis, check to measure Cannara Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cannara Biotech is operating at the current time. Most of Cannara Biotech's value examination focuses on studying past and present price action to predict the probability of Cannara Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cannara Biotech's price. Additionally, you may evaluate how the addition of Cannara Biotech to your portfolios can decrease your overall portfolio volatility.